Business Wire

Aryaka’s Fifth Annual Global State of the WAN Report Reveals Network Insights From 1,350 Global Enterprises

Share

Aryaka®, the leader in fully managed Cloud-First WAN solutions, today published its fifth annual 2021 State of the WAN report, the industry’s foremost survey into global SD-WAN and SASE planning. Key trends identified in this year’s report include:

  • Accelerating fusion of networking and security planning, with almost a third of enterprises stating that they are already deploying what they consider to be a secure access service edge (SASE) architecture
  • A hybrid work environment that will persist after the pandemic recedes, with over 80% stating that they expect over a quarter of workers to remain remote, and over two-thirds desiring flexibility between on-premises and remote deployments
  • Continued WAN and application growth, resulting in increased network complexity. The number of enterprises reporting they’re deploying over 500 distinct applications has grown to 46%. 37% of enterprises identify complexity as their number one network concern
  • 43% of enterprises identify application performance as an underlying driver for WAN transformation. However, WAN transformations have slowed this year due to the pandemic
  • Over 70% of enterprises intend to move to managed services versus just 18% who prefer the autonomy of a do-it-yourself WAN solution

"Every year I look forward to Aryaka's high quality State of the WAN report for information on industry trends,” said Scott Raynovich, founder and chief analyst at Futuriom. “This year, the report reflects many of the same trends we are seeing at Futuriom, which include the ongoing integration of cloud-based networking services and security -- otherwise known as Secure Access Service Edge (SASE) -- as well as strong demand for virtualized networking solutions targeted at Work from Anywhere (WFA) and hybrid work environments. It's a good read!”

Year-on-Year Trends with Changing Challenges and Priorities

The WAN continues to extend its reach, with the number of enterprises connecting to over 100 inter-regional sites growing by 50%, from 19% in 2020 to 28% in 2021. This is coupled with continued application growth, with the number of enterprises stating that they’ve deployed over 500 distinct applications growing to 46%, compared to 32% in 2021. As evidence of collaboration traction, Zoom was identified as critical by 36% in 2021, up from 25% in 2020.

One finding that did not noticeably change year-on-year is complexity, which was identified by 36% of enterprises as their number one network issue. Interestingly, those who identified cost as a major issue grew to 20% in 2021 from 16% in 2020, a 25% increase. This may be attributed to cloud or MPLS cost concerns.

Overall, investment priorities did see recede in some areas, due to tactical pandemic concerns driving near-term planning. For example, only 17% of respondents plan to conduct an SD-WAN/SASE-driven network refresh this year versus 29% in 2020. However, combining this with remote access upgrades, a new entry at 22%, and security, at 21%, results in strong momentum going into 2021. In contrast, LTE/5G experienced growth from 24% in 2020 to 31% in 2021. Finally, VPN investment is at 31% this year versus 27% in 2020. Aryaka believes the new remote workforce, due to the pandemic, led to this VPN increase.

For actual deployment, managed services still reign supreme at 71%, versus 18% who are looking for a do-it-yourself (DIY) solution. Many enterprises are also further along the deployment lifecycle, with 26% evaluating SD-WAN this year, up from 22% in 2020. This increasing market maturity is reflected in a drop in identified barriers to SD-WAN adoption. Enterprises are less concerned that the WAN service won’t address application performance, coming in at 36% this year, versus 43% in 2020, with corresponding drops in SLA concerns, technology maturity, and lack of skills.

A Closer Look at SASE and the Rise of the Hybrid Workplace

Enterprise SASE deployment plans are accelerating, with 29% stating that they are already deploying what they consider to be a SASE architecture. Another 56% are planning to deploy a SASE architecture in the next 12-24 months. As part of a complete SASE architecture, the top capability identified was SD-WAN transport at 34%. And for deployment, over half state that they prefer a solution that includes technology from both their WAN vendor and security specialists, spanning across cloud and the edge.

When the pandemic hit, workers around the world migrated from their offices to their homes, a shift that will also impact future planning and investment throughout 2021. More than half (59%) of the respondents stated they expect 25-50% of their workers to remain remote, while 21% say they are planning for more than 50% of their workforce to continue working from home. Businesses are also prioritizing flexibility, with 63% stating that they consider the ability to quickly move resources between on-premises and remote to be very important.

“The fifth edition of the Global State of the WAN is bigger and better than ever, with survey inputs and insights from over 1350 Enterprises worldwide,” said Shashi Kiran, CMO of Aryaka. “On behalf of Aryaka Networks, I would like to express my gratitude to those who participated in this survey, and hope this serves as an excellent resource and guidebook for all those CIOs, network, cloud and security practitioners to leverage and proactively Plan their WAN™. Of particular interest are the trends focusing on SD-WAN and SASE deployments.”

Study Methodology

The Fifth Annual Global Aryaka 2021 State of the WAN study surveyed over 1350 global IT and network practitioners at enterprises spanning all verticals, headquartered in NA, APAC and EMEA. The survey asked respondents about their networking and performance challenges, priorities and their plans for 2021 and beyond.

Aryaka to Host 2021 The State of the WAN Webinars

Join us at the following dates/times for a lively panel discussion on the “Aryaka 2021 Global State of the WAN.” Regional observations will also be presented:

● North America

March 23, 1pm EST, 10am PST

Register Here

● EMEA

March 23, 3pm GMT

Register Here

● APAC

March 24, 930am IST, Noon Beijing

Register Here

This interactive format allows the panel of experts to deep dive into the Fifth annual State of the WAN report, which will include further analysis of the key findings driving digital transformation.

Download Report Here: https://www.aryaka.com/state-of-wan-2021/
Download Infographic Here: https://www.aryaka.com/docs/aryaka-state-of-the-wan-2021-infographic.pdf

Additional Resources:

  1. Aryaka Managed SD-WAN as-a-Service. This datasheet explains how the Aryaka SmartServices platform is built for the Cloud-First world. Specifically, this means there are no products to buy, and no inventory, deployment hassles, patches or configurations to worry about.
  2. Aryaka’s Cloud-First WAN for Dummies. This e-book explains everything you need to know about consuming your network as-a-Service, how to achieve fully integrated security, and how to make your network as easy as your cloud.

For more on Aryaka, please visit: https://www.aryaka.com/
Visit the Aryaka blog: https://www.aryaka.com/blog/
Follow Aryaka on Twitter: @AryakaNetworks
Visit Aryaka on LinkedIn: https://www.linkedin.com/company/aryaka-networks/

About Aryaka

Aryaka, the Cloud-First WAN company, brings agility, simplicity and a great experience to consuming the WAN-as-a-service for network and security. The company provides an optimized global network and innovative technology stack, delivering the industry’s #1 managed SD-WAN service and setting the gold standard for application performance. Aryaka’s SmartServices platform offers connectivity, application acceleration, security, cloud networking and insights that leverage global orchestration and provisioning. The company’s customers include hundreds of global enterprises including several in the Fortune 100.

Contact information

US Aryaka Media Contact:
Liam Collopy
Executive Vice President
Harden Communications Partners
Ph: 510-488-2472
Lcollopy@hardenpartners.com

UK Aryaka Media Contact:
Inés Mitsou
Account Manager
Positive
Ph: 0770-388-4664
E: imitsou@positivemarketing.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Merck Advances ATR Inhibitor Berzosertib in Small Cell Lung Cancer With New Published Data and Initiation of Phase II Trial With Registrational Intent12.4.2021 18:04:00 EEST | Press release

Merck, a leading science and technology company, today announced key clinical advancements for berzosertib (M6620), an investigational, potent and selective ataxia telangiectasia and Rad3-related (ATR) inhibitor. Berzosertib is the leading asset in the company’s DNA damage response (DDR) inhibitor program and one of the most advanced ATR inhibitors in oncology clinical development industry-wide. Results from a Phase II proof-of-concept study conducted by the US National Cancer Institute (NCI) (NCT02487095)* and published in Cancer Cell showed that berzosertib in combination with the chemotherapy topotecan resulted in an objective response rate (ORR) of 36% among patients with relapsed small cell lung cancer (SCLC), including durable responses among a majority of responding patients with platinum-resistant disease.1 The NCI is also conducting a separate Phase II trial of berzosertib in combination with topotecan versus topotecan monotherapy in SCLC that has relapsed (NCT03896503)* which

Loomis Sayles Welcomes Susan Sieker as Chief Financial Officer12.4.2021 17:15:00 EEST | Press release

Loomis, Sayles & Company, an affiliate of Natixis Investment Managers, announced today that Susan Sieker has joined Loomis Sayles as executive vice president and chief financial officer (CFO). She also joins the Loomis Sayles Board of Directors. Susan reports to Kevin Charleston, chairman and chief executive officer of Loomis Sayles, and will oversee the finance organization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210412005613/en/ Susan joins Loomis Sayles from Cambridge Associates, where she was the chief financial officer and oversaw financial planning and analysis, treasury, accounting operations, financial reporting, payroll and taxes. Prior to joining Cambridge Associates in 2012, Susan served in a variety of finance and risk leadership roles at Brinker International, including vice president and treasurer, vice president of global infrastructure, vice president of benefits, vice president of business assurance

Alira Health Strengthens Its Growth Strategy With a $35M Funding, Led by Creadev12.4.2021 16:00:00 EEST | Press release

Alira Health (www.alirahealth.com), a leading international advisory firm dedicated to advancing healthcare and life sciences, announced it has closed a $35M equity financing led by Creadev, an evergreen investment company backed by the Mulliez family. This new partnership will help accelerate the firm’s growth strategy, focused on merging pharmaceutical, medical and digital technologies development with medical care through a patient-centric approach. “I would like to thank our team of investors for joining our mission to enable healthcare transformation. Their investment positions us to change the way life sciences advisory services are delivered,” said Gabriele Brambilla, Chief Executive Officer and Co-Founder of Alira Health. “We are building a powerful continuum of services that spans the product and solutions development life cycle, supported by the recent additions of our patient engagement, real-world evidence and advanced analytics practices. This financing allows us to advanc

KD Pharma Acquires Phytoextract and CBD Manufacturing Assets12.4.2021 15:45:00 EEST | Press release

The KD Pharma Group has acquired the manufacturing assets of a Swiss-based cannabinoid manufacturer. The assets give KD Pharma access to technology for producing Active Pharmaceutical Ingredients (APIs) based on phytocannabinoids and other plant extracts. The technology further expands KD’s lipid technology portfolio and can be used in combination with KD’s other fractionation and separation technologies. “KD Pharma is a leader in lipid technology focused primarily on omega-3s, but our technology suite has applications in other lipid sources like cannabinoids,” said Oscar Groet, CEO of the KD Pharma Group. “We have committed to expanding our technology portfolio to develop APIs from cannabinoids and plant extracts,” Groet continued, “and these assets give KD Pharma additional pathways to develop new products for this emerging market.” The KD Pharma Group has also licensed a novel extraction method from Herbolea Biotech S.r.l. and expects to have a complete, licensed cGMP manufacturing

Mirum Pharmaceuticals and Vivet Therapeutics Enter into Exclusive Worldwide Option and License Agreement for Vivet’s Gene Therapy Programs Targeting Progressive Familial Intrahepatic Cholestasis12.4.2021 15:00:00 EEST | Press release

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) and Vivet Therapeutics (“Vivet”) announced today an agreement whereby Mirum has the exclusive option to develop and subsequently commercialize Vivet’s two proprietary AAV gene therapy programs for progressive familial intrahepatic cholestasis (PFIC), subtypes 3 and 2. The two programs, VTX-803 and VTX-802, are currently being evaluated in preclinical studies by Vivet, a privately-held gene therapy biotechnology company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210412005354/en/ Under the terms of the agreement, Vivet will continue to advance the preclinical studies for VTX-803 and VTX-802 for PFIC3 and PFIC2, respectively. Mirum has the exclusive option to license the programs after which Mirum would lead the clinical development and any future commercialization of the programs. Until that time, Mirum will provide funding to support the continued research and development costs

Globality and BT Sourced Announce New Partnership to Unleash the Power of Procurement12.4.2021 15:00:00 EEST | Press release

Through a new partnership with Globality and BT’s new procurement company, BT Sourced, BT launched Globality’s AI-powered Smart Sourcing® Platform to transform how BT employees source and procure services. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210412005173/en/ “BT’s changing and so is procurement. Digitization is the driving force for long-term growth and value to the BT customer and operating model,” said Cyril Pourrat, Chief Procurement Officer, BT. “Partnering with Globality will help us to embrace digital technology and simplify our processes.” “Having immediate access to our current suppliers and Globality’s diverse global network will bring agility and new value to our teams,” added Pourrat. BT now uses Globality’s AI advisor, Glo™, to quickly and easily source the best suppliers for consulting, marketing, IT, HR, legal and other service categories. “BT is revolutionizing the way it sources services in order t

FLIR Wins DARPA Contract Worth Up to $20.5M to Develop Revolutionary New Protective Fabrics for Chem-Bio Defense12.4.2021 15:00:00 EEST | Press release

FLIR Systems, Inc. (NASDAQ: FLIR) announced it has won a contract with the Defense Advanced Research Projects Agency (DARPA) to rapidly develop novel fabrics with embedded catalysts and chemistries that can fight and reduce chemical and biological threats upon contact. The revolutionary fabrics will be incorporated into protective suits and other equipment such as boots, gloves, and eye protection that can be worn by troops on the battlefield, medical experts, healthcare workers, and more. FLIR received $11.2 million in initial funding for the potential five-year effort worth up to $20.5 million, including options. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210412005140/en/ The Personalized Protective Biosystems (PPB) program will create fabrics with built-in ability to fight chemical and biological agents, from VX to chlorine gas to Ebola virus. The revolutionary fabrics being developed by FLIR Systems will be incorpora

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom